Synthesis and characterization of norfloxacin biomonomer

Abstract

A novel drug agent named norfloxacin biomonomer was developed in order to solve the problem of low drug content, uneven drug distribution, low molecular weight, and wide molecular weight distribution of polymer drug, based on polyurethane, which was used as an antibacterial agent to control the bacterial infection associated with biofilm formation on polymeric materials used in biologic environments. In this research, norfloxacin biomonomer was synthesized by esterifying the compound of norfloxacin. High-performance liquid chromatography system was used to analyze the purity of the final product and intermediate products, and Fourier transform infrared spectrometer and mass spectrum were used to verify the final product and intermediate products. The results showed that the objective product was developed successfully. The final product of norfloxacin biomonomer could be incorporated into the polyurethane as chain extender.

Keywords

norfloxacin / biomonomer / synthesis / characterization

References

[1] Jansen B, Peters G. Modern strategies in the prevention of polymer-associated infections. Journal of Hospital Infection, 1991, 19(2): 83-88

[2] Shummugaperumal T, Narayanan V, Annick L. The potential of lipid-and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. Journal of Controlled Release, 2008, 1: 2-22

[3] Robert F P. Infection in ventricular assist devices: the role of biofilm. Cardiovascular Pathology, 2006, 5: 264-270

[4] Lakshmi S N, Cato R L. Biodegradable polymers as biomaterials. Progress in Polymer Science, 2007, 8: 762-798

[5] Yang M L, Santerre J P. Utilization of quinolone drugs as monomers: characterization of the synthesis reaction products for poly(norfloxacin diisocyanatododecane polycaprolactone). Biomacromolecules, 2001, 2(1): 134-141

[6] Connie S K, Wan C X, Sara H, James D B, Thomas A H, Buddy D R. Design of infection-resistant antibiotic-releasing polymers. I. Fabrication and formulation. Journal of Controlled Release, 1999, 3: 289-299

[7] Woo G L Y, Mittelman M W, Santerre J P. Synthesis and characterization of a novel biodegradable antimicrobial polymer. Biomaterials, 2000, 21(12): 1235-1246

[8] Paul S J, Li M U S. <patent>Patent, 20050255079Al</patent>

[9] Jiang X, Li J H, Ding M M, Tan H, Ling Q Y, Zhong Y P, Fu Q. Synthesis and degradation of nontoxic biodegradable waterborne polyurethanes elastomer with poly(ϵ-caprolactone) and poly(ethylene glycol) as soft segment. European Polymer Journal, 2007, 43(5): 1838-1846

[10] Mehkam M, Nasser S S. Preparation of new biodegradable polyurethanes as a therapeutic agent. Polymer Degradation & Stability, 2003, 80(2): 199-202

Acknowledgments

This work was supported by the program of the Fujian Provincial Department of Science & Technology (No.2006I0019) and supported by the Science and Technology Department of Fujian Province Subsidization Provincial University Projects (2008F50502) and the Fujian Provincial Key Laboratory of Polymer Materials.

RIGHTS & PERMISSIONS

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg